BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2002
View Archived Issues
Novel antibacterial spiro compounds claimed in RiboTargets patent
Read More
Synthesis and use of new tachykinin antagonists reported by Boehringer Ingelheim
Read More
Senju patents novel Na+/Ca2+ exchange inhibitors
Read More
New erythromycin analogues identified at GSK and Pliva
Read More
Tanabe Seiyaku presents novel substance P antagonists
Read More
Tulane and Biomeasure team claims urotensin-II antagonists
Read More
Estrogen receptor modulators and their use in osteoporosis, etc.
Read More
Natural products with potent and selective metallo-beta-lactamase-inhibitory activity
Read More
Potential antiulcer drug from natural sources under study in Chile
Read More
Insmed's oral insulin sensitizer improves glycemic control, lipid profiles and beta-cell function
Read More
Dose-response profile for SomatoKine in insulin-requiring type 2 diabetes patients
Read More
Evidence of low toxicity reported for the radiotracer [18F]-F-A-85380
Read More
The human nicotine conjugate vaccine TA-NIC is reported to be safe for adult smokers
Read More
New data on the efficacy and safety of licofelone in the treatment of osteoarthritis
Read More
AC-2993 is an effective and safe agent for type 1 and 2 diabetes mellitus
Read More
Insulin receptor activator designed by Telik reverses indinavir-induced insulin resistance
Read More
Preliminary clinical data reported for components of gene-directed enzyme prodrug therapy
Read More
AxCell enters into CRADA with NCI to research TEY1 for prostate cancer
Read More
Isis and Lilly expand antisense alliance into cancer
Read More
Product R cleared for phase I solid tumor trial
Read More
Periostat enters clinical study for meibomianitis
Read More
Lorus and NCI collaborate on GTI-2040 phase II program
Read More
131I-TM-601 to enter phase I/II for glioma
Read More
Phase III results announced for INS-365 Ophthalmic in dry eye
Read More